DOCSLIB.ORG

Cancer-Brochure-12-A5.Qxd:Layout 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cancer-Brochure-12-A5.Qxd:Layout 1 JOURNALS CANCER RESEARCH 2012 www.iospress.com IOS PRESS JOURNAL PROGRAM All IOS Press journals are published online and in print Visit www.iospress.com to: • Enter your subscription online • Check all subscription options including backfiles • Purchase articles on a pay-per-view basis • Obtain a free electronic sample copy • Scan tables of contents • Set up a journal alert • Find complete Instructions for Authors Open Library® : Open Access at IOS Press In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to use, download, circulate, and disseminate by everyone, wherever in the world, as long as proper attribution is given to the author and the original source. The Open Library® option is available to all authors and for all journals published by IOS Press. IOS PRESS EBOOKS PROGRAM www.booksonline.iospress.com • Place your order online for ebooks or hardcopy books • Browse tables of contents • Read abstracts and preliminary pages free of charge • Search by subject or book series • Buy single titles and gain immediate access • Become a member and gain full access to all titles JOURNALS Analytical Cellular Pathology Impact Factor: 4.169* Calculated based on Cellular Oncology articles published in 2007-2008 ISSN 2210-7177 (print) ISSN 2210-7185 (online) Analytical Cellular Pathology focuses on the burgeoning applications of physical techniques to the study of cells, tissues and organs in disease to elucidate pathogenesis and further translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways that aberrant biochemical and molecular pathways are transduced into the physical processes that underlie pathogenesis. The journal appeals to an audience of pathologists, cell biologists and biochemists, as well as biomedical engineers by focusing on new applications of the rapidly evolving array of technologies. Papers should be based on novel concepts, novel methodologies or the novel use of existing methodologies that contribute to the study of pathologic processes, rather than methodological details only. Approaches include tools such as biomedical photonics, surface resonance phenomena and impedance tomography, as well as new approaches for ultra-high resolution magnetic resonance, multispectral, hyperspectral and vibrational mode analysis and computational biology models. Hypothesis generating and hypothesis-testing observational studies are also welcome. Editor-in-Chief Brief History Stanley Cohen, MD, University of Medicine & Dentistry of New Jersey, Analytical Cellular New Jersey Medical School, Newark, NJ, USA Pathology was Email: [email protected] launched in 1988, changed its name Coordinating Editor to Cellular Oncology Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USA between 2005 and Email: [email protected] 2009 and then in Associate Editors 2010, reverted to Ulysses J. Balis, USA Richard Levenson, USA Analytical Cellular Elaine Bearer, USA Jonathan Reichner, USA Pathology: Cellular Hilary Coller, USA Thomas Ried, USA Oncology. In 2011 it Walter Giaretti, Italy Gordon W. Stamp, United Kingdom continues as Analytical Ronald H. Goldfarb, USA Ronald S. Weinstein, USA Cellular Pathology. Abstracting & Indexing Coverage Academic Source Complete, Biochemistry & Biophysics Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Current Contents/Clinical Medicine, Current Contents®/ Life Sciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Science Citation Index Expanded (SciSearch®), Science Citation Index® (*Wos), SciVerse Scopus, SIIC Data Bases, Ulrich’s Periodicals Directory Instructions for Authors www.iospress.com/journal/analytical-cellular-pathology Subscription Information 2012 Volumes 34-35 (12 issues) *Journal Impact Factors from Journal Citation Reports® Institutional subscription (print & online): US$2120 / €1504 Science Edition 2009, published (including postage & handling) by Thomson Reuters ©2010 Institutional subscription (online only): US$1955 / €1390 Individual subscription (online only): US$300 / €250 Breast Disease An International Journal ISSN 0888-6008 (print) ISSN 1558-1551 (online) The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will impact patient outcome. This research, that spans basic science, clinical medicine, epidemiology and public policy, poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also, it is important to understand the public implications of these discoveries. Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implications of recent research on a specific problem in breast cancer. Meeting the information needs of scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer research or clinical management. Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging and social and legal issues. Editor-in-Chief Jeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected] Founding Editor Edison T. Liu, MD, Executive Director, Genome Institute of Singapore Abstracting & Indexing Coverage Academic Source Complete, Cancer Prevention and Control Database, Chemical Abstracts Service (CAS), EBSCO Databases, Elsevier BIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE, Prenatal Smoking Cessation Database, PubMed, SciVerse Scopus, Ulrich’s Periodicals Directory Instructions for Authors www.iospress.com/journal/breast-disease Subscription Information 2012 Volume 34 (4 issues) Institutional subscription (print & online): US$646 / €460 (including postage & handling) Institutional subscription (online only): US$590 / €420 Individual subscription (online only): US$175 / €150 Cancer Biomarkers Impact Factor: 2.418* ISSN 1574-0153 (print) ISSN 1875-8592 (online) Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor- in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted. Editor-in-Chief Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Email: [email protected] Associate Editors William E. Grizzle, MD, PhD Anna Lokshin, PhD Attila T. Lorincz, PhD Paola Muti, MD Harvey Pass, MD Tesshi Yamada, MD, PhD Abstracting & Indexing Coverage Academic Source Complete, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Elsevier BIOBASE, Embase, EMBIO, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Citation Index Expanded (SciSearch®), SciVerse Scopus, Ulrich’s Periodicals Directory Instructions for Authors www.iospress.com/journal/cancer-biomarkers Subscription Information 2012 Volumes 11-12 (12 issues) Institutional subscription (print & online): US$1653 / €1180 (including postage & handling) Institutional subscription (online only): US$1485 / €1060 Individual subscription (online only): US$300 / €250 *Journal Impact Factors from Journal Citation Reports® Science Edition 2010, published by Thomson Reuters ©2011 Disease Markers Impact Factor: 1.723* ISSN 0278-0240 (print) ISSN 1875-8630 (online) Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including: • Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA- sequences) • Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states • Amplification of knowledge about existing markers • Family studies of markers in disease • New techniques for identification and/or isolation of important marker molecules • Use of monoclonal antibodies for the definition of molecular structures associated with disease markers • Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction
Load more

Recommended publications
  • California State Physician and Surgeon License
    Curriculum Vitae MANOJ TIMOTHY ABRAHAM, M.D., F.A.C.S. 845-454-8025 – Office 845-454-8026 – Fax [email protected] www.NYfaceMD.com OFFICE LOCATIONS Facial Plastic, Reconstructive & Laser Surgery / Oasis Medispa 82 North Water Street Poughkeepsie, NY 12601 ENT Faculty Practice 1055 Saw Mill River Road Ardsley, NY 10502 New York Eye & Ear Infirmary 310 East 14th Street New York, NY 10006 EDUCATION UNDERGRADUATE 1989-1993 Bachelor of Science Brown University, Providence, RI Biology with Honors GRADUATE 1993-1997 Doctor of Medicine Cornell University Medical College, New York, NY INTERNSHIP 1997-1998 General Surgery Lenox Hill Hospital, New York, NY RESIDENCY 1998-1999 Otolaryngology Manhattan Eye, Ear & Throat Hospital, New York, NY Head & Neck Surgery 1999-2002 Otolaryngology- New York University Medical Center, New York, NY Head & Neck Surgery FELLOWSHIP 2002-2003 Facial Plastic Surgery University of California, Los Angeles Medical Center and Micro-vascular Los Angeles, California Reconstruction LICENSURE & CERTIFICATION LICENSURE 1997 - New York State Medicine and Surgery License 1997 - Drug Enforcement Agency Registration 2002 - California State Physician and Surgeon License Manoj Timothy Abraham, M.D., F.A.C.S. Curriculum Vitae, July 6, 2018 CERTIFICATION 1997 - National Board of Medical Examiners 2003 - American Board of Otolaryngology – Head & Neck Surgery, MOC expires 2023 2005 - American Board of Facial Plastic and Reconstructive Surgery, MOC expires 2025 APPOINTMENTS & EMPLOYMENT ACADEMIC POSITIONS 2014 – present Attending Faculty,
    [Show full text]
  • Findings, September 2002
    INDINGS FNational Institutes of Health September 2002 National Institute of General Medical Sciences inside Baldomero Olivera Secrets of the Killer Snails 2 Elaine Bearer Cells in Motion 8 Edited by Alison Davis under contract 263-MD-20519 Produced by the Office of Communications and Public Liaison National Institute of General Medical Sciences National Institutes of Health On the Cover Photo of Baldomero Olivera: Kerry Matz Photo of Elaine Bearer: John Forasté Editor’s Note Getting together. More than ever, that’s what science is all about. If you think being a scientist means being lonely, you’re wrong! Researchers spend most of their days working with other people. Biomedical scientists at colleges and universities spend up to half of their time teaching some area of biology or chemistry to undergraduate and graduate students. And scientists continually work with students to help turn neat ideas into testable research projects and to sort through the results of an experiment. But biomedical researchers also do a lot of talking to other scientists, and not just biologists. As biology research broadens to include new fields like computer science, physics, and engineering, thinking together about how to attack a problem in an unconventional way can be the most fertile ground for discovery. In assembling the materials for this issue of Findings, the importance of cooperation between scientists became undeniably apparent. Upon asking researchers to review the words about their work, these hard-working women and men insisted on giving credit wherever possible to their students and coworkers—all the people who sit at the benches in their labs and do experiments day in and out.
    [Show full text]
  • Annual Report 2018
    ANNUAL REPORT 2017-2018 Table of Contents 2 Director’s Letter 3 History and Mission 4 Faculty 8 Faculty News 12 Faculty Research Programs 22 Scientific Advancements 34 Collaborations 46 Academic and Community Activities 51 Faculty Publications FY 2018 59 Teaching 62 Postdoctoral Trainees 64 Visiting Scientists 65 Graduate Students 69 Grants and Contracts 77 Events 77 Zilkha Seminar Series 80 8th Annual Zach Hall Lecture 82 Los Angeles Brain Bee 84 Soprano and Musical Ambassador Renée Fleming visits Zilkha 85 Music to Remember – LA Opera/Alzheimer’s Greater Los Angeles 86 Searching for Solutions: 5th Annual AD Symposia Held at Zilkha Institute 87 Administration and Operating Budget 88 Development 1 Director’s Letter Dear Friends, The year 2018 began with a strong start when the department of Physiology & Neuroscience was ranked number 3 in the nation according to the Blue Ridge Institute. I am proud of the work we have done to achieve this great honor and in awe of our faculty who have made this accomplishment possible, by receiving a large number of federal awards for their research. Of course, as much as we love to have well-funded research programs, it is the science that really matters, and as you will see across the following pages, we have made great strides in so many different areas, from neural circuits and genomics, to imaging and Alzheimer’s. I am proud of the work we are doing and happy to be recognized for it. In addition to awards received, we welcomed a number of visitors and speakers who came to the Zilkha Neurogenetic Institute, some to share their cutting-edge research, others to learn of the advances we have made.
    [Show full text]
  • Scientific Program & Events Guide
    American Society for Investigative Pathology Experimental Biology 2021 – Virtual and Interactive 2021 Scientific Program & Events Guide Tuesday - April 27, 2021 Symposium: The Gut Microbiota and Disease - Session I 8:30 AM - 11:30 AM Chair: Xiao-Ming Yin, MD, PhD ▪ Tulane University Co-Chairs: Wenke Feng, PhD ▪ University of Louisville Maria Pilar Alcaide, PhD ▪ Tufts University José Otero, MD, PhD ▪ The Ohio State University Session Description: Humans carry a vast number of bacteria and other microbiota species from birth, and you may be more bacteria than you are you. An increasing importance of microbiota in human health and diseases has been recognized. Whatever your research subjects are, chances are that they may be influenced by the microbiota. This symposium will discuss the impact of gut microbiota on diseases ranging from neurodegeneration to diabetes, from the liver to the heart, and from the immune cells to the bone. • Chair - Welcome and Introductions • 8:30 AM - 9:00 AM Gut Microbiota, Bile Acids Receptor, and Metabolism John YL Chiang, PhD ▪ Northeast Ohio Medical University • 9:05 AM - 9:35 AM Hepatic Autophagy, Microbiota, and Liver Injury Xiao-Ming Yin, MD, PhD ▪ Tulane University • 9:40 AM - 10:10 AM Gut Microbiota, Fatty Liver Disease, and Hepatocellular Carcinoma Bernd Schnabl, MD ▪ University of California, San Diego • 10:15 AM - 10:45 AM Intestinal Barrier Function and Metabolic Liver Disease Wenke Feng, PhD ▪ University of Louisville • 10:50 AM - 11:20 AM Fecal Transplantation and Immune Regulation in Liver Disease
    [Show full text]
  • Five Researchers Share a Love of the Arts, from Composing Music to Fine Art Photography
    BY RICH HOLMES | PHOTOGRAPHY BY DANIELLE MACINNES FIVE RESEARCHERS SHARE A LOVE OF THE ARTS, FROM COMPOSING MUSIC TO FINE ART PHOTOGRAPHY. HERE’S A CLOSER LOOK AT THESE INDIVIDUALS WHOSE CREATIVITY GOES BEYOND THE LAB. he tiny community of Woods Hole overflows with both science and art. It’s home to world-renowned marine research institutions, an active community theater, an annual film festival and a mix of music groups and events. Small wonder, then, that these two realms Toverlap and influence each other in this rich, cerebral atmosphere. On the following pages, we profile five researchers whose artistic endeavors range from hobby to second career. Music and the brain fascinate Elaine Bearer. She studied Sidney Tamm’s cartoons have been published musical composition in Paris under Nadia Boulanger and in scientific newsletters and have appeared in ads received her master’s degree from New York University. She for Zeiss microscopes. He also sells artwork at Lo- subsequently completed a combined Ph.D.-M.D. at Univer- cal Colors Gallery in Woods Hole. Colorful organ- sity of California, San Francisco, and has taught both science ic shapes of waves and marine animals comprise and music courses: First at Brown University and now at the one piece at the gallery. Other pieces blend pen and University of New Mexico. She has brightly hued bits of paper to portray ctenophora, spent many summers working at also known as comb jellies or sea gooseberries. the Marine Biological Laboratory, “Most laypeople put scientists and artists into where her research has explored the separate boxes,” says Tamm.
    [Show full text]
  • Annual Report 2017
    Zilkha Neurogenetic Institute ANNUAL REPORT 2016 - 2017 The period covered in this report is July 2016 through June 2017. All photos are by Chris Shinn unless otherwise noted. Special thanks to Emily Chu for her work preparing this report. 2 CONTENTS 4 Director’s Letter 5 History and Mission 7 ZNI Faculty 10 Faculty News 14 Faculty Research Programs 22 Scientific Advancements 33 Academic and Community Activities 37 Collaborations 48 FY 15 Faculty Publications 66 Teaching 69 ZNI Postdoctoral Trainees 72 ZNI Graduate Students 76 Zach Hall Travel Award Winners 77 NRSA Grant Training 78 Grants and Contracts ZNI Events 90 ZNI Seminar Series Special Lectures 93 7th Annual Zach Hall Lecture 94 Mary Hayley and Selim Zilkha Chair in Alzheimer’s Disease Research 95 4th Annual Zilkha Symposium on Alzheimer’s Disease & Related Disorders ZNI Collaborative Events 96 Joint ADRD ZNI Pilot Program 97 Los Angeles/Irvine Brain Bee 98 Music to Remember 99 ZNI Administration 100 ZNI Development 3 Director’s Letter As I complete my 5th year as Director of the Zilkha Neurogenetic Institute (ZNI), I find myself reflecting on the many significant advances this outstanding group of researchers has made, while I also consider all the exciting developments the new era may hold. Most similar institutes have been around decades longer than ZNI, which is just over 12 years old, yet our accomplishments–detailed in this report–rival or best some of the leading research neuroscience institutes in the world. For example, we continue to secure grants from a wide breadth of sponsors and in FY17 we increased our external funding to $24.3M in total costs.
    [Show full text]
  • JANUARY 2006 ASCB NEWSLETTER 3 ASCB Council Report
    ASCB JANUARY 2006 NEWSLETTER VOLUME 29, NUMBER 1 Beckerle ASCB Holds 45th Annual Meeting Becomes President in San Francisco Page 2 Council Approves 2007 Budget, Reviews Programs, Meets with CSR Director, Bad Budget Welcomes New Staff Amidst healthy reserves and strong financial performance, the for NIH ASCB Council met last month to review programs and publi- Page 31 cations, consider new initiatives, and continue to usher publi- cations and meetings into the 21st century. Zena Werb of the University of California, San Call for Francisco, who completed Science, Networking: and Sessions: New Nominations her term as President at year- science presented at end, presided over the two- poster sessions (above), Page 44 day Council meeting. Mary students socialize Beckerle, of the University at the Reception for Undergraduate Poster MBC InCytes of Utah Huntsman Cancer Presenters, and (below) Page 50 Institute, became President Bruce Alberts Award January 1st, and Bruce winner Samuel Silverstein Alberts became President- (left) and 2006 President-Elect elect. Larry Goldstein com- Bruce Alberts. Inside pleted his term as Secretary, and Jean Schwarzbauer assumed the role this month. In addi- tion, other Council members present included: Treasurer Gary President’s Column 2 Ward; Past-President Harvey Lodish; Councilors Kerry Bloom, ASCB Council Report 4 Tony Bretscher, Juan Bonifacino, David Burgess, Peter Devreotes, Linda Hicke, Kathryn Howell, Caroline Kane, Erin Keane ASCB Committee Reports 8 O’Shea, and Janet Shaw; and Councilor-elect Sandra Masur. Annual Meeting Highlights 18 See Council Report, page 4 Public Policy Briefing 31 Dear Labby 34 Join the Congressional ASCB Profile 35 WICB Column 40 Liaison Committee Concerned about government funding for cell biology research? Not sure how to participate in ASCB ad- Member Gifts 41 vocacy on research funding and science policy issues? The Congressional Liaison Committee (CLC) of the Members in the News 42 Joint Steering Committee provides you with the tools you need to influence decisionmakers.
    [Show full text]
  • Download PDF Brochure
    5th Annual World Congress of IBMISPS August 26-29, 2008 Held at The University of California, Los Angeles © Brad Feinknopf Contents About IBMISPS 1 Mission Statememt & Educational Objectives Board of Directors 2 Founder’s Address 3 Babak Kateb Jean-Jacques Lemaire’s Address 4 Warren Grundfest’s Address 5 Patrick Soon-Shiong’s Address 6 Leonard Rome’s Address 7 Tuesday, August 26 Program 8-13 Wednesday, August 27 Program 14-17 Thursday, August 28 Program 18-22 Coctail Award Dinner 23-28 Friday, August 29 Program 29-33 Sponsors 34 Program Development Committee 35 International Brain Mapping and Intraoperative Surgical Planning Society Mission Statement and Educational Objectives MISSION STATEMENT IBMISPS is a non-profit organization designed to encourage all scientists who are interested or currently active in areas of Brain Mapping (BM) and Intraoperative Surgical Planning (ISP) to share their findings with other physicians and scientists across the disciplines. The Society also promotes public welfare through the advancement of ISP and BM, its commitment to excellence in education, and by dedication to research and scientific discovery. The mission of IBMISPS will be achieved through a multidisciplinary collaboration of government agencies, patient advocacy groups, educational institutions, and the private sector. Together, issues related to Brain Mapping and Intraoperative Planning can be addressed and new technologies implemented to benefit patient care. EDUCATIONAL OBJECTIVES Upon completion of the scientific meeting, participants should be able to: • Identify new findings in brain mapping • Describe and assess the latest and Intraoperative surgical planning technology in Brain Mapping and most relevant to their own field, such Intraoperative surgical planning.
    [Show full text]
  • Actin-Binding Proteins from Drosophila Embryos: a Complex Network of Interacting Proteins Detected by F-Actin Affinity Chromatography Kathryn G
    Actin-binding Proteins from Drosophila Embryos: A Complex Network of Interacting Proteins Detected by F-actin Affinity Chromatography Kathryn G. Miller, Christine M. Field, and Bruce M. Alberts Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94143 Abstract. By using F-actin affinity chromatography of 13 proteins tested). The distributions of antigens columns to select proteins solely by their ability to observed suggest that groups of these proteins cooper- bind to actin filaments, we have identified and partially ate in generating unique actin structures at different purified >40 proteins from early Drosophila embryos. places in the cell. These structures change as cells These proteins represent *0.5 % of the total protein progress through the cell cycle and as they undergo present in soluble cell extracts, and 2 mg are obtained the specializations that accompany development. The by chromatography of an extract from 10 g of em- variety of different spatial localizations that we have bryos. As judged by immunofluorescence of fixed em- observed in a small subset of the total actin-binding bryos, 90% of the proteins that we have detected in proteins suggests that the actin cytoskeleton is a very F-actin column eluates are actin-associated in vivo (12 complex network of interacting proteins. T HF. Drosophila embryo develops as a large highly rows. However, the actin underlying the furrows plays an im- organized syncytial cell during the first 14 nuclear portant role in their formation, and it differs in function, division cycles. Within this large cell, regions of the organization and regulation from the actin filaments underly- cytoplasm differ from each other in organization and struc- ing the rest of the membrane.
    [Show full text]
  • 2017-2018 Handbook Combined M.D. and Ph.D. Program
    2017-2018 Handbook Combined M.D. and Ph.D. Program Biomedical Research Education Programs Combined M.D. and Ph.D. Program Table of Contents INTRODUCTION ..................................................................................................................................................... 4 CONTACT INFORMATION ...................................................................................................................................... 5 Section 1: PROGRAM GOALS AND OBJECTIVES .................................................................................................... 2 Section 2: GUIDANCE AND COUNSELING OF MD/PHD STUDENTS ....................................................................... 4 Section 3: PROGRAM MILEPOSTS ......................................................................................................................... 5 YEAR 1 (M.D. Program, Phase 1-Year 1) MILEPOSTS ........................................................................................ 5 YEAR 2 (M.D. Program, Phase 1-Year 2) MILEPOSTS ........................................................................................ 5 YEAR 3 (Ph.D.) MILEPOSTS ................................................................................................................................ 6 YEAR 4 (Ph.D.) MILEPOSTS ................................................................................................................................ 8 YEAR 5 (Ph.D.) MILEPOSTS ...............................................................................................................................
    [Show full text]
  • Pathfinder WINTER 2021
    WINTER 2021 PathFINDER PathFINDER WINTER 2021 Welcome to this fall/winter installment of PathFINDER, our departmental newsletter where we connect you to the latest in UNM Pathology notable events. As we enter our second year of the COVID-19 pandemic, this issue has several feature articles spotlighting some of the COVID-19-related work undertaken by our faculty, essential in UNM’s efforts to take care of our patients afflicted by the virus. Dr. Kendall Crookston tells of his week working on UNMH’s COVID-19 inpatient service and Dr. Jay Raval reports on some of the COVID-19 clinical trials ongoing in our Transfusion Medicine and Therapeutic Pathology group. 1. WELCOME FROM NANCY JOSTE, MD In recognition of Dr. Larry Sklar’s retirement last fall and his career-long achievements, we highlight his time as 3. FEATURE: TRANSFUSION MEDICINE AND THERAPEUTIC PATHOLOGY Director of the Center for Molecular Diagnostics. This feature tells the impressive history of the CMD through the eyes of Dr. Sklar, as well as from a number of his esteemed CMD colleagues through the years. 5. FEATURE: ON BECOMING AN INPATIENT COVID SERVICE ATTENDING Our department lost one of our Pathology resident team with the sudden passing of Dr. Maryam Sayah. Maryam 7. FEATURE: REFLECTIONS ON THE CENTER FOR MOLECULAR DISCOVERY finished her residency with us in 2020 and had commenced a hematopathology fellowship at UCLA. She was an engaging and kind colleague and always had a smile. She is truly missed. Our deep condolences to her family. 16. MAKE A GIFT 17. FACULTY NEWS As we move further into 2021, we are clearly not done with COVID-19 and the need for continued strong vigilance in prevention measures.
    [Show full text]
  • UNIVERSITY of NEW MEXICO AFFILIATED HOSPITALS Albuquerque, NM
    UNIVERSITY OF NEW MEXICO AFFILIATED HOSPITALS Albuquerque, NM PROGRAMS OFFERED The Department of Pathology [http://pathology.unm.edu] is committed in equal measure to education, patient care, and scholarly investigation, in order to prepare physicians for diverse career opportunities. We offer a four- year program of combined training in anatomic and clinical pathology. Anatomic pathology training includes extensive exposure to general surgical pathology, cytology, autopsy and forensic pathology, and immunohistology. Clinical pathology training is supported by TriCore Reference Laboratories (TriCore), which is a large regional laboratory serving the UNM Health System, the Presbyterian Healthcare System, community hospitals, and clients throughout the state and surrounding areas. Excellent training is offered for the resident, under the supervision of the faculty, in all aspects of pathology with a focus on patient care and the consulting role of the pathologist to both primary care and specialty clinicians. The Department is on the cutting edge in many areas of scientific investigation; support is provided for those residents who wish to pursue research studies. Advanced fellowship subspecialty training is offered in multiple fields. Please visit our website at: [http://pathology.unm.edu]. TYPES AND NUMBERS OF APPOINTMENTS The current house staff includes 16 residents, as well as fellows in hematopathology (4), forensic pathology (4), molecular genetic pathology (2), transfusion medicine (1), surgical pathology (1), cytopathology (1), and 2 post- sophomore fellows. Four first year residency positions are available each year. FACILITIES The University of New Mexico Hospital and the New Mexico Veteran's Administration Medical Center are the primary teaching hospitals used by the University of New Mexico Health Sciences Center.
    [Show full text]